Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Thymus Regeneration, Immunorestoration, and Insulin Mitigation Extension Trial

NCT04375657 is registered in ClinicalTrials.gov with Intervene Immune, Inc. as lead sponsor.

NCT NCT04375657
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04375657 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Thymus Regeneration, Immunorestoration, and Insulin Mitigation Extension Trial
Lead sponsor
Intervene Immune, Inc.
Phase
Phase 2
Overall status
Recruiting
Start date
November 23, 2020
Completion date
December 31, 2025
Enrollment
85 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epigenetic aging, immunosenescence